Bio-Synthesis, Inc. Pioneers the Use of Multi Functional Bridged Nucleic Acid for Diagnostic, Clinical, and Therapeutic Applications
August 26, 2013 11:00 ET
|
Bio-Synthesis, Inc.
LEWISVILLE, Texas, Aug. 26, 2013 (GLOBE NEWSWIRE) -- As a pioneer in oligonucleotide synthesis, Bio-Synthesis, Inc. has been pursuing the development of new oligonucleotide based technologies that can...